Showing results (401-410 of 558) with videos related to
Sort By:
Pageof 56
Respiratory Research|February 15, 2011
β-Thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-upMaria De Santis, Rosanna Inzitari, Silvia L Bosello, et al.European Urology|November 7, 2017
Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another StandardNicolas Mottet, Maria De Santis, Erik Briers, et al.RMD Open|February 2, 2026
Comparative effectiveness and persistence of ixekizumab and other b/tsDMARDs in patients with PsA from a real-world setting: 12-month results from the PRO-SPIRIT studyHelena Marzo-Ortega, Philipp Sewerin, Carlo Selmi, et al.Advances in Therapy|July 3, 2024
Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate CancerMaria De Santis, Sara Martínez Breijo, Paul Robinson, et al.Hepatology (Baltimore, Md.)|February 4, 2005
Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosisYasuhiko Kimura, Carlo Selmi, Patrick S C Leung, et al.Journal of Autoimmunity|January 8, 2008
Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasiaYuko Nakanishi, Koichi Tsuneyama, Makoto Fujimoto, et al.Journal of Medicinal Chemistry|July 28, 2015
Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex: Toward a Peptide-Based Diagnostic Assay for Primary Biliary CirrhosisGiulia Pacini, Alfonso Carotenuto, Cedric Rentier, et al.Journal of Autoimmunity|November 10, 2009
A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosisNancy Agmon-Levin, Yinon Shapira, Carlo Selmi, et al.Cell Communication and Signaling : CCS|November 8, 2024
Cell damage shifts the microRNA content of small extracellular vesicles into a Toll-like receptor 7-activating cargo capable to propagate inflammation and immunityValentina Salvi, Carolina Gaudenzi, Barbara Mariotti, et al.Hepatology (Baltimore, Md.)|November 25, 2015
Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept studyGideon M Hirschfield, M Eric Gershwin, Richard Strauss, et al.Pageof 56